Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

IDEXX Laboratories Raises FY2025 GAAP EPS Guidance from $12.40-$12.76 to $12.81-$13.01 vs $12.62 Est; Raises FY2025 Sales Guidance from $4.205B-$4.280B to $4.270B-$4.300B vs $4.232B Est

Author: Benzinga Newsdesk | November 03, 2025 06:33am
IDEXX Laboratories (NASDAQ:IDXX) raises FY2025 GAAP EPS guidance from $12.40-$12.76 to $12.81-$13.01 vs $12.62 analyst estimate. Raises FY2025 sales outlook from $4.205 billion-$4.280 billion to $4.270 billion-$4.300 billion vs $4.232 billion estimate.

Posted In: IDXX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist